Lawmakers express concerns over NCAA's data sales to sportsbooks.

  • State Senators raise concerns regarding NCAA's decision.
  • NCAA to sell data to sportsbooks amid health advocacy.
  • Public health implications addressed by lawmakers.

In a recent statement, State Senators John F. Keenan of Massachusetts and Paul Moriarty of New Jersey expressed their concerns regarding the NCAA's decision to sell gambling data to sportsbooks. They highlighted the potential consequences of such actions, especially in the context of public health and the integrity of sports. The senators emphasized that the decision may exacerbate gambling issues among vulnerable populations.

The senators' statement was made in collaboration with the Public Health Advocacy Institute, which aims to address the health implications of gambling legislation. They argued that the NCAA's move could lead to increased gambling activity and negatively impact public health initiatives. By selling data to sportsbooks, they believe the NCAA may be prioritizing profit over the welfare of student-athletes and the broader community.

This joint statement underscores the ongoing debate about gambling in sports, with concerns about its effects on mental health and addiction. Senators Keenan and Moriarty urge stakeholders to consider the potential risks before proceeding with data sales that could further normalize gambling in sports.

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

HelpMeSee Unveils Next-Generation MSICS Training System at SAFO

New training system aims to improve global solutions for blindness. HelpMeSee launches…

Volta Labs and Watchmaker Genomics Partner for DNA Library Prep Kit

New Callisto Complete Kit simplifies DNA library preparation for researchers. Volta Labs…

Barr Brands Celebrates 80 Years in Business and 30 Years of Employee Ownership

Memphis company marks long-standing commitment with its workforce Barr Brands marks 80…

Generate Biomedicines, Inc. Announces Pricing of Initial Public Offering

Generate Biomedicines sets IPO pricing as public offering progresses. Generate Biomedicines announces…